(Q40380034)

English

Mutations in both env and gag genes are required for HIV-1 resistance to the polysulfonic dendrimer SPL2923, as corroborated by chimeric virus technology

scientific article published on January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Mutations in both env and gag genes are required for HIV-1 resistance to the polysulfonic dendrimer SPL2923, as corroborated by chimeric virus technology (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Anne-Mieke Vandamme

9

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

10

object named as

Zeger Debyser

0 references

Barbara Van Remoortel

3

object named as

Barbara Van Remoortel

0 references

object named as

Erik De Clercq

8

0 references

Peter Cherepanov

5

object named as

Peter Cherepanov

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Anke Hantson

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Valery Fikkert

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Barbara Van Remoortel

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Chistophe Pannecouque

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Barry Matthews

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

George Holan

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Myriam Witvrouw

11

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Antiviral Chemistry & Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

253-266

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

HIV entry and its inhibition

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

env chimeric virus technology for evaluating human immunodeficiency virus susceptibility to entry inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Specific incorporation of cyclophilin A into HIV-1 virions

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Nucleosides. V. The Monomesylates of 1-(2'-Deoxy-β-D-lyxofuranosyl)thymine1,2

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A.

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

HIV chemotherapy

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Inclusion of full length human immunodeficiency virus type 1 (HIV-1) gag sequences in viral recombinants applied to drug susceptibility phenotyping

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Human immunodeficiency virus type 1 hijacks host cyclophilin A for its attachment to target cells

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Effective lowly cytotoxic analogs of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II).

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140.

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Fusion inhibition--a major but costly step forward in the treatment of HIV-1.

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Managing resistance to anti-HIV drugs: an important consideration for effective disease management.

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Sulfated polysaccharides extracted from sea algae as potential antiviral drugs

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600405

21 January 2018

Identifiers

10.1177/095632020501600405

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40380034&oldid=1896477410"